Flyte Aviation, Inc. (NYSE American: VJET) announced record financial results for the third quarter ended September 30, 2026, filing an -K with the SEC on November 16, 2026. The company reported quarterly aviation revenue of $1.838 million, marking a 145% sequential increase.
Financial results for the period were impacted by the classification of legacy MedTech segment assets as Held for Sale. Consequently, the company reported a net loss of $15.1 million for the quarter. This loss includes a $13.3 million non-cash impairment charge related to the MedTech assets and a loss from continuing operations of $1.9 million. MedTech revenue for the quarter increased 4% sequentially and 24% year-over-year to $280,000.
On the operational front, the company achieved high fleet utilization, fulfilling more than 99% of customer flights using its own aircraft rather than third-party charters. Total flight hours increased 129% sequentially, with the average time flown per leg averaging 52 minutes. The company noted that this operational momentum validates its business strategy of providing short-hop private aviation at a competitive price.
Flyte Aviation is currently in the process of expanding its fleet. Three aircraft have completed pre-purchase inspections and are anticipated to begin revenue service in the current December quarter. Concurrently, the company has received regulatory approvals to expand operations into Canada and has launched a direct-to-consumer booking platform and a Flyte Club membership program.
Additionally, the company signed a non-binding letter of intent on November 1, 2026, to sell its Catheter Precision medical-device assets. The transaction is targeted for completion by year-end 2026 and is intended to complete the company's transition to a pure-play private aviation company.